Combination Therapy Regimen For Treatment Of Selected HCV Genotypes

A method for the treatment of hepatitis C infection genotype 1, 2, 4, 5, or 6, but not genotype 3 is provided comprising administering an effective amount of a combination of Compound (I), Compound (II), and Compound (III), or independently optionally their pharmaceutically acceptable salt, solvate...

Full description

Saved in:
Bibliographic Details
Main Authors Van Remoortere Peter, Deshphande Milind, Chanda Sushmita Mukherjee, Hui James, Picchio Gaston Rafael, Beumont Maria Gloria, Apelian David, Bijnens Lieve, Van Dijck Alex, Blatt Lawrence M, Kakuda Thomas Naoki, Mertens Roel, Mahadevan Sivi, Chen Dawei, Jans Eugene, Fry John, Phadke Avinash
Format Patent
LanguageEnglish
Published 25.01.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A method for the treatment of hepatitis C infection genotype 1, 2, 4, 5, or 6, but not genotype 3 is provided comprising administering an effective amount of a combination of Compound (I), Compound (II), and Compound (III), or independently optionally their pharmaceutically acceptable salt, solvate or hydrate, optionally in a solid fixed dose composition.
Bibliography:Application Number: US201715656821